In Brief
SUMMARY
Blood platelets are critical for hemostasis and thrombosis and play diverse roles during immune responses. Despite these versatile tasks in mammalian biology, their skills on a cellular level are deemed limited, mainly consisting in rolling, adhesion, and aggregate formation. Here, we identify an unappreciated asset of platelets and show that adherent platelets use adhesion receptors to mechanically probe the adhesive substrate in their local microenvironment. When actomyosin-dependent traction forces overcome substrate resistance, platelets migrate and pile up the adhesive substrate together with any bound particulate material. They use this ability to act as cellular scavengers, scanning the vascular surface for potential invaders and collecting deposited bacteria. Microbe collection by migrating platelets boosts the activity of professional phagocytes, exacerbating inflammatory tissue injury in sepsis. This assigns platelets a central role in innate immune responses and identifies them as potential targets to dampen inflammatory tissue damage in clinical scenarios of severe systemic infection.
INTRODUCTION
Approximately 750 billion platelets circulate in human blood, constantly scanning the vasculature for damage of the endothelial surface. Upon encountering endothelial injury or inflammation, platelets are immediately recruited in a well-characterized cascade of events, including initial platelet tethering and rolling, followed by platelet activation, adhesion, and spreading, eventually leading to fibrin(ogen)-dependent aggregation and subsequent thrombus retraction (Jackson, 2011; Brass et al., 2005) . Once recruited from the blood stream, platelets are considered sessile, attaching firmly and spreading on whatever subendothelial matrix or plasma protein they first encounter. This is consistent with the view that anucleate platelets, unlike most other blood cells, are unable to migrate.
Cell migration is critically involved in many physiological and pathological processes, including embryonic development, tumor metastasis, and immune responses. Cell migration on adhesive surfaces involves repetitive cycles of four major sequential steps: (1) extension of a protrusion (leading edge); (2) adhesion to a substrate; (3) contraction of the cytoplasm; and (4) release from contact sites (Lauffenburger and Horwitz, 1996) . These cycles both require and maintain morphological polarization, often characterized by a steering leading edge lamellipodium and a trailing cell body. Quantitative morphometric analyses revealed that leading edge morphology mainly depends on actin polymerization coupled to cell matrix adhesion assembly, whereas the trailing edge of a migrating cell is largely shaped by myosin-IIa-mediated contraction and adhesion disassembly (Barnhart et al., 2011; Yam et al., 2007) . Both processes have to be tightly coordinated to generate traction force and forward movement; their balance determines overall cell shape and speed (Gupton and Waterman-Storer, 2006) . Even though platelets are considered to be stationary cells once recruited from the circulation, they possess all molecular assets required for cell migration (Bettex-Galland and Luescher, 1959) . Correspondingly, earlier studies proposed that platelets have the capacity to undergo locomotion (Lowenhaupt et al., 1973; Feng et al., 1998; Pitchford et al., 2008; Kraemer et al., 2010) . However, the existence of active platelet migration has not been established on a cell biological level. In particular, whether autonomous platelet migration occurs in a physiological context in vivo and serves a biological function has not been demonstrated.
Whereas platelets are classically recognized for their major role in hemostasis and thrombosis (Jackson, 2011) , they also evolved a large variety of non-hemostatic, mainly immunologic functions (Semple et al., 2011; Yeaman, 2014) . Platelets are among the first cells recruited to sites of inflammation and infection and play an essential role in initiating intravascular immune responses (Wong et al., 2013) . Accordingly, platelets coordinate the recruitment of a variety of immune cells and instruct them with their effector programs (Sreeramkumar et al., 2014; Guidotti et al., 2015) . Platelets also have the ability to directly fight pathogens by releasing anti-microbial mediators and/or physically trapping and encapsulating invaders, thus preventing dissemination with the blood flow (Yeaman, 2014; Wong et al., 2013) . Importantly, most of these platelet effector functions require the formation of tight platelet-pathogen interactions. To fully understand how platelets execute their immunologic functions, it is therefore essential to develop a better picture of how these interactions are regulated on a cell biological level. Here, we identify platelet migration as an autonomous platelet function and show that migration of single platelets enables them to collect and bundle bacteria and to boost neutrophil activation.
RESULTS

In Vivo Tracing of Single Platelets at Sites of Vascular Injury and Inflammation Reveals Unidentified Patterns of Motility
To study the fate of individual platelets at sites of vascular injury and inflammation, we generated a multicolor platelet reporter mouse (Figures S1A and S1B) by crossing PF4-Cre and R26R-Confetti mice, which permitted us to track individual platelets with unique single-cell contrast using intra-vital two-photon (2P-IVM) microscopy in a needle-and a laser-injury model (Figures 1A, 1B, and S1C) . Using single-cell resolution analysis, we observed a fraction of adherent platelets in the periphery of the injury ( Figure S1D ), which remained motile and rearranged its position independent of the collective retraction within the thrombus, suggesting autonomous motility (Figures 1C and S1E; Movie S1). The mean velocity of these platelets was significantly lower and migration paths were less straight compared to platelet rolling and retraction ( Figures 1C-1H and S1F).
The directionality was independent of blood flow, and platelets were able to migrate against the blood stream, indicating an active process rather than passive translocation ( Figure 1E ). Platelet migration is independent of clot retraction (Auger and Watson, 2008; Ono et al., 2008) , because tracks of migrating platelets were not directed toward the centroid of injury (Figures 1D and 1F) . Platelet motility was also not influenced by migrating leukocytes (Sreeramkumar et al., 2014) , because it was not affected when we depleted leukocytes prior to experiments (Figures S1G and S1H) .
Spreading Platelets Are Motile and Have a Polarized Shape
To address the mechanistic basis of platelet migration, we mimicked the physiological microenvironment of vascular injury and inflammation in vitro by adding mouse or human-plateletrich plasma (PRP) to coverslips precoated with subendothelial fibrillar collagen and plasma ( Figure S2A ). Platelets that encountered immobilized collagen fibers immediately started to spread and recruited additional platelets from the supernatant, forming immotile micro-aggregates. In contrast, spreading platelets that did not contact collagen fibers rearranged their morphology and became motile ( Figure S2A ). Initiation of motility was associated with a characteristic change in platelet morphology (Figure 2A) . Spreading platelets showed a fried-egg-like shape with high circularity (aspect ratio z1). Platelets then polarized by protruding one side of the lamellipodium and simultaneously retracting the opposite side. During this process, the pseudonucleus moved from the center to the rear of the platelet. At the same time, the now-migrating platelet adopted a half moon shape reminiscent of highly motile fish keratocytes (Keren et al., 2008) , resulting in an increase of the aspect ratio to approximately 2 ( Figure 2B ; Movie S2). We found this to be the characteristic phenotype of persistently migrating platelets (Figures 2B and S2B) . Migration and shape changes were resistant to shearing flow at arterial velocities, and platelets were able to migrate against flow direction, further indicating a cell-autonomous, active process ( Figure S2C ).
In most eukaryotic cells, shape change and maintenance are active cellular processes requiring assembly and disassembly of actin filaments (Pollard and Cooper, 2009) . Consequently, when we inhibited actin polymerization, platelets immediately stopped migrating followed by a loss of polarization and a decrease in the projected platelet area ( Figures 2C, 2D , and S2D; Movie S2). Loss of platelet polarization mainly resulted from loss of leading edge lamellipodia, indicating that migration depends on branched lamellipodial actin networks. Indeed, inhibition of actin branching abrogated platelet migration ( Figure 2E ). Hence, platelet locomotion is an active process initiated by a cascade of morphological changes that depend on branched lamellipodial actin networks. (legend continued on next page) trigger the release of secondary platelet mediators. Hence, we hypothesized that migration of platelets requires paracrine priming through soluble mediators released by platelets interacting with collagen. To test this, we examined platelet migration on collagen-free coverslips in the presence of supernatant from either collagen-activated or resting platelets (see STAR Methods). Supernatant from collagen-activated platelets, but not from resting platelets, promoted platelet migration (Figure S3A) . Pretreatment with indomethacin and apyrase to inhibit paracrine signaling via TXA2 and ADP, the two major agonists released by collagen-activated platelets, significantly attenuated the effect of platelet supernatant on migration ( Figures S3A and  S3B ). On the other hand, ADP and U46619 induced platelet migration in the absence of supernatant from collagen-activated platelets ( Figure 3A ; Movie S3). This suggests that platelet activation by the soluble mediators ADP and TXA2 is both sufficient and required to trigger and maintain platelet migration. Leukocytes use integrin-mediated adhesion when migrating over vascular surfaces (Nourshargh et al., 2010) . Platelets also carry several integrin receptors, including aIIbb3 integrin, which promotes platelet spreading upon activation by agonists, such as ADP and TXA2 (Nieswandt et al., 2002) . We found activated aIIbb3 integrin distributed in clusters along the lamellipodium during migration ( Figure 3B ). When we incubated migrating platelets in the presence of soluble linear H-Arg-Gly-Asp-Ser-OH (RGDS) peptides, which block RGD binding to b integrins, the number of spreading, lamellipodium-forming platelets was significantly reduced with a decrease in both mean platelet area and aspect ratio ( Figures S3C and S3D ). At the same time, platelet migration was virtually abolished ( Figure S3D ). The few platelets that still managed to migrate in the presence of RGDS did so only for short durations ( Figure S3D ). To address whether aIIbb3 integrin directly mediates migration or rather supports migration indirectly by inducing platelet spreading, we allowed human platelets to first spread and migrate before adding C7E3-Fab, the b3 integrin-specific blocking Fab fragment. Upon C7E3-Fab exposure, platelets immediately stopped migrating while initially maintaining their spread morphology ( Figures 3C and 3D ). In contrast, specific inhibition of avb3 (LM609), the second platelet integrin comprising the b3 subunit, had no effect on either spreading or migration ( Figure S3E ). aIIb integrin-deficient mouse platelets and human platelets from a patient with Glanzmann thrombasthenia expressing defective aIIbb3 integrin, adhered to immobilized plasma by developing filopodia rather than the usual lamellipodia. Consequently, these platelets neither showed spreading nor migration (Figures S3F and S3G) . In contrast, platelets from mice lacking b1 integrins or GPIba, the two other major platelet adhesion receptors, spread and migrated normally ( Figure S3F ). This identifies a critical and direct involvement of aIIbb3 integrin in the process of platelet migration.
Because fibrinogen is the physiological ligand of aIIbb3 integrin and was highly enriched in the 15-nm-thick layer of immobilized blood plasma ( Figure S3H ), we addressed whether fibrinogen is sufficient to promote platelet migration. Fibrinogen alone induced robust spreading, but not migration of platelets ( Figure S3I ), indicating the requirement for additional plasma components. Indeed, migration was reconstituted when we added serum to purified fibrinogen ( Figure 3E ). In terms of platelet morphology, the increase in migration was paralleled by an increase in platelet polarization (aspect ratio) and in membrane ruffles at the leading edge (measured by the normalized curvature; Figure 3F ; Movie S3). By systematic analysis of serum fractions in terms of their impact on both platelet migration and morphology ( Figure S3J ), we identified albumin and calcium as the two additional serum components required for characteristic platelet shape change and migration on fibrinogen (Figures 3G, 3H, . Whereas immobilized albumin likely lowers substrate adhesiveness of fibrinogen ( Figure S3R ; Park et al., 1991) and thus induces membrane ruffling (Borm et al., 2005;  affecting normalized curvature; Figures S3L, S3O, and S3Q), the presence of free calcium is required for platelet polarization (affecting aspect ratio; Figure 3H ; Movie S3). Consequently, at physiological conditions (in the presence of calcium-rich serum), migration and shape of activated platelets was ultimately determined by the adhesiveness of the substrate .
Extracellular Calcium Mediates the Switch from
Spreading to Migration by Myosin-IIa-Dependent Trailing Edge Formation Intracellular calcium levels play a fundamental role in the control of platelet function (Varga-Szabo et al., 2009 ) and the polarization of migrating cells (Brundage et al., 1991) . We therefore tested whether extracellular calcium supports migration by controlling intracellular calcium oscillations. In calcium-free buffer, spreading platelets remained sessile while showing only minimal intracellular calcium oscillations. In contrast, amplitudes increased 8-fold in the presence of extracellular calcium and platelets became polarized and started to migrate ( Figure 4A ; Movie S4). Depletion of intracellular calcium by BAPTA-AM significantly reduced platelet migration without affecting platelet spreading ( Figure 4B ; Movie S4). Elevation of intracellular calcium has been shown to control migration through activation of myosin IIa, generating contractile forces necessary for rear retraction and adhesion release (Lee et al., 1999) . We found activated myosin IIa mainly localized at the trailing edge of migrating platelets ( Figure 4C ). The activity of myosin IIa depends on (E) Phase contrast micrographs from platelets treated with CK666 (50 mM) and control (CK689; 50 mM). Membrane roughness measured by the normalized curvature of platelet contours is shown (CK666: n = 67; CK689: n = 53; smooth density histograms displaying normalized curvature [x axis] as a density function [y axis]; percentage of migrating platelets was quantified; n = 5 experiments; mean ± SEM); Student's t test; *p < 0.05; **p < 0.01. See also Figure S2 and Movie S2. myosin light chain phosphorylation (pMLC) and is regulated by calcium-dependent myosin light chain kinase (MLCK) (Yang and Huang, 2005) . Platelet pMLC levels were significantly higher in the presence of calcium compared to a calcium-free microenvironment or after intracellular calcium depletion ( Figure 4D ). Inhibition of myosin-IIa-mediated contraction with blebbistatin had no impact on platelet spreading but dose dependently prevented migration ( Figure 4E ; Movie S5). Population-based morphology analysis revealed significantly increased aspect ratios of blebbistatin-treated platelets, suggesting that platelets still polarize ( Figure 4F Figure S4C ).
Migrating Platelets Act as Mechano-scavengers
We were interested whether the mechanical forces generated by myosin contractions contribute to adhesion release by disruption of cytoskeletal-to-integrin or of integrin-to-substrate bonds or rather by removal of the integrin-bound substrate. Immunofluorescent tracking of actin and aIIbb3 integrin revealed that only a minor fraction of cytoskeleton components and/or integrins are ripped off the rear of migrating platelets ( Figure S5A ). In contrast, migrating platelets efficiently removed fibrinogen from the surface, a process depending on aIIbb3 integrin ligation and actomyosin contraction ( Figures 5A-5E , S5B, and S5C; Movie S6). Covalently bound fibrinogen remained attached to the surface, confirming that removal is mechanical and does not involve proteolysis ( Figure 5F ). Once removed, fibrinogen is transported toward the center (pseudonucleus) of migrating platelets remaining on the platelet surface, mainly within invaginations of the open canalicular system (OCS) (Figures 5G and S5D ; Movie S6). Because fibrinogen forms insoluble fibrin polymers at sites of vascular injury and inflammation in vivo (Prasad et al., 2015) , we performed platelet migration assays in the presence of immobilized fibrin strands. Platelets efficiently migrated on and removed and accumulated large fibrin fibers, indicating that both migration and migration-dependent ligand removal is not restricted to soluble fibrinogen molecules (Figures S5E-S5G ; Movie S6). Indeed, migrating platelets even collected largersized latex particles bound to the fibrin(ogen) matrix (Figures 5H and 5I; Movie S6) . Thus, migrating platelets act as mechanosensors that probe the mechanical resistance of their local microenvironment. The high contraction and adhesive forces generated by individual platelets (Lam et al., 2011) couple migration to efficient mechanical scavenging of bound objects ( Figures 5H-5J ).
Migrating Platelets Bind and Collect Bacteria
Platelets are among the first cells recruited to sites of tissue injury. Besides their crucial role in forming blood clots and preventing severe bleeding, platelet activation within injured and inflamed tissues also provides a first line of defense against potential pathogenic invaders (Yeaman, 2014). We thus hypothesized that the scavenging function of single migrating platelets may boost the ability of platelets to fight infection. Because platelets possess bactericidal and phagocytic-like activities (Yeaman, 2014; White, 2005) , we examined their ability to migrate and collect fibrin-bound bacteria using live-cell microscopy. Similar to the latex particles, different species of bacteria (Escherichia coli, Staphylococcus aureus, and Listeria monocytogenes) were readily collected and accumulated at the pseudonucleus together with fibrin(ogen)-forming bundles of more than 3 bacteria (>20 mm 2 ; Figures 6A-6C and S6A-S6C; Movie S7). Platelet-bound bacterial bundles were more resistant to shear stress, accomplishing efficient bacterial trapping ( Figure 6D ). MYH9-deficient platelets were significantly less effective in collecting, bundling, and containing fibrin-bound bacteria due to their inability to migrate ( Figures 6D, 6E , S6C, and S6D).
Next, we infected mice systemically with Escherichia coli (E. coli) to address whether platelets also form bacterial bundles in vivo. E. coli sepsis causes fibrin formation in various organs, including the liver (Massberg et al., 2010) and triggers the recruitment of bacteria and individual platelets to the hepatic microcirculation (McDonald et al., 2012; Figures S7A-S7C) . Recruited platelets remained motile in vivo and migrated several microns independent of leukocytes ( Figures 7A, 7B , S7D, and S7E; Movie S7). Autonomously migrating platelets were significantly slower than platelets bound to leukocytes, reaching migration speeds comparable to those found in vitro and at sites of vascular injuries . The kymograph highlights the immediate stop of migration after treatment (pink arrow), whereas leading edge shrinkage followed with a temporal delay. Measurements of leading edge speed and platelet area further revealed this temporal delay of lamellipodium shrinkage as indicated by the width of the pink bar. (D) Percentage of migration before and after treatment; n = 3 experiments; mean ± SEM; paired t test. (E and G) Migration quantified for indicated treatments (in the presence of 150 mg/mL fibrinogen). Platelets were pooled from n = 4 (E) or n = 3 (G) experiments; mean ± SEM; ANOVA/Tukey HSD. (F and H) Platelet shapes and density histograms are shown for different concentrations of serum (F) and calcium (H) . Kruskal-Wallis/Wilcox. (I) Migration quantified for indicated fibrinogen concentrations (in the presence of 1,500 mg/mL serum); n = 4 experiments; mean ± SEM; ANOVA/Tukey HSD. *p < 0.05; **p < 0.01. See also Figure S3 and Movie S3. Figure S7I ). Together, this shows that migrating platelets also collect and bundle bacteria in vivo. This is not restricted to E. coli, because we obtained similar results with a clinically important methicillin-resistant Staphylococcus aureus (MRSA) isolate (USA 300; Figures 7E, S7H, and S7I).
We then evaluated whether bundling by migrating platelets facilitates bacterial killing. Whereas activated platelets can directly kill MRSA in the absence of immune cells, their bactericidal activity depends on platelet secretion (Ali et al., 2017), but not platelet migration or the formation of bundles ( Figure S7J ). Rather than promoting direct killing, microbe collection by migrating platelets boosts the activity of professional phagocytes. By time-lapse microscopy, we observed in vitro that migrating polymorphonuclear neutrophils (PMNs) slow down, arrest (Figure S7K; Movie S7) , and engage in phagocytosis ( Figure S7L ; Movie S7) once they encounter bacterial bundles formed by migrating platelets. During this process, PMNs reveal increased intracellular calcium oscillations ( Figure S7M ; Movie S7). They also release neutrophil extracellular traps (NETs) ( Figure S7N ), reflecting PMN activation at sites of platelet-bacteria bundles. Inhibition of platelet migration and bacterial bundling by genetically removing MYH9 diminishes the formation of NETs ( Figure S7N ). We further show in vivo that bundling of bacteria by migrating platelets also promotes activation of PMNs upon infection with MRSA. PMNs interact with platelet-bacteria bundles, form multicellular Ly6Gpve aggregates, and release NETs in hepatic microvessels of MRSA-infected mice ( Figure S7O ). Aggregate formation and NETosis are significantly reduced in PF4-Cre+/MYH9 fl/fl mice, indicating that collection and bundling of bacteria by migrating platelets supports these processes ( Figures 7F-7H , S7P, and S7Q). MRSA survives intracellularly upon phagocytosis and triggers neutrophil-induced cytolysis, leading to a dramatic and often deadly increase in neutrophildriven inflammation (Greenlee-Wacker et al., 2015) . Consistent with the hepatotoxic effect of NETs (Kolaczkowska et al., 2015) , abrogation of platelet migration not only reduced neutrophil activation and NETosis but also attenuated liver damage, whereas clearance of MRSA from the liver was not affected ( 
DISCUSSION
Previous studies reported that platelets recruited to vascular injuries (Lowenhaupt et al., 1973) or sites of inflammation can change their position (Pitchford et al., 2008; Kraemer et al., 2010) . However, direct in vivo evidence of autonomous platelet locomotion was lacking and fundamental questions regarding the underlying mechanisms remained unaddressed. This has resulted in a general skepticism as to whether true autonomous migration of platelets exists in the mammalian organism. Non-mammalian vertebrates, including birds, have nucleated thrombocytes (Belamarich et al., 1966) . However, this property has not been conserved during the evolution of specialized mammalian platelets, which are released as cytoplasmic fragments from megakaryocytes and no longer possess a nucleus. Consequently, the ability of mammalian platelets to migrate is linked to the fundamental question of whether cells can migrate despite the absence of a nucleus. The nucleus is important for de novo transcription, and its removal has originally been associated with impaired motility in amoebae (Clark, 1942) . Meanwhile, however, experimentally derived enucleated cytoplasmic fragments of protozoan and metazoan cells have been shown to migrate without considerable impairment, indicating that the essential machinery driving locomotion is positioned within the Mean accumulated distances of motile platelets are shown; migration was independent of platelet labeling (see Figure S4B) ; n = 5 mice; bar, mean; paired t test. *p < 0.05; **p < 0.01; scale bars, 5 mm. Also see Figure S4 and Movies S4 and S5.
cytoplasm and does not necessarily depend on a nucleus (Euteneuer and Schliwa, 1984) . Therefore, in theory, the platelet as a terminally differentiated anucleate cell fragment containing all contractile elements necessary for locomotion should also be able to migrate (Bettex-Galland and Luescher, 1959). Indeed, we show here persistent migration of single platelets in vitro and in vivo, providing direct evidence for anucleate cell migration under physiological conditions in mammals, a phenomenon of potential relevance beyond platelet biology (Yount et al., 2007; Yipp et al., 2012) . Previous studies showed that platelet motility Also see Figure S5 and Movie S6.
requires intracellular calcium as well as actin polymerization, suggesting an active process (Schmidt et al., 2011 (Schmidt et al., , 2012 Kraemer et al., 2010) . However, the biomechanical principles underlying platelet migration still remain elusive. Initiation of forward locomotion on 2D surfaces requires the transduction of myosin-generated forces at adhesive sites, thus facilitating their release (Lauffenburger and Horwitz, 1996) . Consequently, conditions where traction forces are dominated by adhesive forces render platelets immobile. As such, most studies analyzing platelet spreading and adhesion were performed on highly adhesive substrates, likely impeding migration. The correlation of adhesiveness and migration has systematically been studied in different cell types (Palecek et al., 1997; Gupton and Waterman-Storer, 2006) , including cytoplasmic fragments (Grę becka et al., 1997), but not in platelets. Here, we systematically analyzed platelet shape change and locomotion on immobilized blood plasma components. Our study shows that the balanced co-adsorption of pro-adhesive fibrinogen and anti-adhesive albumin (Park et al., 1991) determines the ability of the substratum to initiate and maintain polarization and integrin-dependent locomotion of spread platelets. We identified platelet migration as an active cell-autonomous and physiological process at sites of vascular injury and thrombosis in vivo that is resistant to arterial shear forces. Whereas platelet migration as a slow process is unlikely to contribute to rapid thrombus formation, our data suggest a role during thrombus reorganization and consolidation where the ability to migrate may allow platelets to reposition within the lesion while at the same time reorganizing the fibrin(ogen) network (Lam et al., 2011) . Our data illustrate that platelet aggregates are no longer to be considered static but rather represent dynamic structures constantly reorganizing due to platelet motility. (B) Autonomous platelet migration is distinct from passive leukocyte-mediated motility. Migration/adhesion was quantified in leukocyte-deficient animals (depletion; anti-Ly6G/C clone: RB6-8C5). Leukocyte-dependent passive platelet motility was quantified in leukocyte-proficient animals (also see Figure S7E ). Adhesion: n = 14 (pooled from 2 mice); migration: n = 26 (pooled from 2 mice); leukocyte bound: n = 53 (pooled from 3 mice); red bars, mean; Kruskal-Wallis/ Wilcox; *p < 0.05. (C) Platelets interact with and bundle E. coli in vivo. The scale bar represents 5 mm. (D) Platelet and bacteria recruitment and fraction of E. coli bundles >20 mm 2 colocalizing with platelets were quantified in liver sections of septic leukocyteproficient mice (also see Figure S7H ); n = 6 mice (PF4-Cre+/MYH9 fl/fl -BM chimeras); mean ± SEM; Student's t test; *p < 0.05.
Platelets are specialized sentinels of the circulation equipped with a plethora of receptors allowing to respond and stick to almost any surface foreign to human blood, including many pathogens. When spreading over small particles like fibrin fibers, latex beads, or bacteria, platelets can fully cover these objects and secure them within invaginations of their OCS, a continuous invagination of the outer plasma membrane (White, 2005) . The observation that the distended portions of the OCS, which contain engulfed objects, are not phagocytic vacuoles led to propose a ''covercyte,'' rather than a ''phagocyte'' function of platelets (White, 2005) . Here, we show that migrating platelets use actomyosin-dependent forces to mechanically probe their microenvironment. If an encountered object does not resist these pulling forces, it is translocated toward the center of the migrating platelet, remaining attached to the platelet surface or the OCS. In the case of pathogens, this leads to the formation of stable bacterial packages at the platelet surface secured by the large actomyosin forces of individual platelets. Interestingly, platelet-bound bacterial bundles resemble the structural organization of typical platelet-dependent bacterial biofilms, as found in many infectious diseases, such as infective endocarditis (Jung et al., 2012) . Intravascular immunity in invertebrates like Limulus horseshoe crabs is largely established by migrating hemocytes that share common features with mammalian platelets (Levin, 1988) . Consequently, it is tempting to speculate that platelets, the first cells sealing vascular lesions in mammals, may have retained their ability to migrate and to collect pathogens from these ancient amoebocytes, thereby establishing the first line of host defense. Our data therefore provide a mechanism supporting and further explaining the previously proposed covercyte function of platelets that was not fully understood at the cell biology level.
The liver microcirculation provides a unique vascular platform, orchestrating several innate immune mechanisms acting together to combat blood-borne infections (Jenne and Kubes, 2013) . The dense network of Kupffer cells lining liver sinusoids both efficiently captures bacteria from the circulation while at the same time providing adhesion signals to recruit circulating platelets (Wong et al., 2013) . We now show that platelets adherent to the liver vasculature actively migrate to scan their microenvironment for bacteria, accumulating these pathogens on their surface. At the same time, platelets provide an ''adhesion platform'' for neutrophils (Sreeramkumar et al., 2014) , which interact and phagocytose platelet-bound bacteria bundles. This leads to robust neutrophil activation and release of NETs. Boosted neutrophil activation by migrating platelets is detrimental in case of infection with MRSA, a pathogen that survives intracellularly upon phagocytosis and leads to a dramatic and often deadly increase in neutrophil-driven inflammation (Greenlee-Wacker et al., 2015) . Abrogation of platelet migration reduces neutrophil activation and NETosis and attenuates tissue damage.
Together, evolution provided circulating blood platelets not only to prevent blood loss after injury but also as an efficient defense line to constantly scan the vascular system for potential invaders. Once platelets are recruited to sites of bacterial infection, they start to migrate, which enables the collection and bundling of bacteria and to recruit and activate professional phagocytes. The orchestration of these two functions assigns platelets a central role in innate immune responses and identifies them as potential target to dampen inflammatory tissue damage in certain clinical scenarios.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (E) Platelet and bacteria recruitment and fraction of MRSA bundles >8 mm 2 colocalizing with platelets were quantified in liver sections of septic leukocyteproficient mice (also see Figure S7I ); n = 9/10 liver sections from 5 mice; mean ± SEM; Student's t test; *p < 0.05. Also see Figure S7 and Movie S7. Turbill, P., Beugeling, T., and Poot, A.A. (1996) . Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene. , 2007) . aIIbÀ/À mice were a gift of Dr. Frampton (Emambokus and Frampton, 2003) . GPIb-hIl4R-mice were a gift of Dr. Ware (Kanaji et al., 2002) . All strains were backcrossed to and maintained on C57BL/6-background. If not otherwise stated, animals of same sex and age were randomly assigned to experimental groups. For sepsis experiments, knockout and control animals were paired according to age, sex and weight. All procedures performed on mice were approved by the local legislation on protection of animals (Regierung von Oberbayern, Munich).
STAR+METHODS KEY RESOURCES TABLE
Human blood donors
Human blood was drawn from male and female healthy voluntary donors at the age of 25-40 after informed consent was obtained from all subjects. Both genders were equally represented in all our analyses. Migration assays performed in this study did not reveal gender-specific differences (data not shown). Blood from a patient with type I Glanzmann thrombasthenia was collected after approval from the ethical review board (LMU Munich) and written informed consent.
Bacterial strains
Methicillin-resistant Staphyloccocus aureus (MRSA) MRSA (strain USA300) was cultured in brain heart infusion (BHI, Bacto TM Brain Heart Infusion (Porcine), BD) medium at 37 C with 180 rpm shaking. The CFU (colony forming units) per milliliter (ml) was determined for OD 600 = 0.1 with 2*10 8 CFU/ml. For infection experiments S. aureus USA300 was inoculated in BHI medium (37 C, 180 rpm) overnight. The overnight culture was diluted in BHI to OD 600 = 0.1 and further incubated at 37 C with 180 rpm for 1.5 h. Subsequently, OD 600 was measured and adjusted to OD 600 = 1.25 which equals 5*10 8 CFU/200 ml. Bacteria were washed once with 0.9% Sodium chloride solution (Braun) and kept on ice until injection. E. coli E.coli (strain DH12) was cultured in LB-broth medium (LB Broth (Luria lowsalt) Powdermicrobialgrowth medium, Sigma Aldrich, Steinheim) medium at 37 C with 260 rpm shaking. The CFU (colony forming units) per milliliter (ml) was determined for OD 600 = 1.0 with 2,8*10 8 CFU/ml. For infection experiments E.coli from a frozen stock was inoculated in LB-broth medium with 1 mM IPTG (1:100 IPTG, Isopropyl b-D-1-thiogalactopyranoside; Sigma Aldrich Chemie, Steinheim) and 100mM Ampicillin (1:1000 Ampicillinsodiumsalt, Sigma Aldrich Chemie, Steinheim) (37 C, 260 rpm) overnight. A starter culture of the saturated overnight culture was prepared the next morning in a 1:1000 dilution with LB-broth medium (1:1000), 1 mM IPTG (1:100) and 100mM Ampicillin (1:1000) and further incubated at 37 C with 250rpm for 2.5 h to allow growth to early log phase. Subsequently, OD 600 (reading of 0,3-0,4) was measured and the needed volume adjusted to OD 600 = 1.0 which equals 2,8*10 8 CFU/ml to get an injection volume of 100ml per animal with a concentration of 3,2*10 8 CFU. Bacteria were washed twice with 0.9% Sodium chloride solution (Braun) and kept on ice until injection. Listeria monocytogenes (LM) LM WT strain 10403S were grown to exponential phase at 37 C in BHI broth, washed, resuspended in PBS. LM was fluorescently labeled by incubation for 30 min at 37 C with 5mM CSFE (carboxyfluorescein diacetate succinimidyl ester; Sigma). Bacteria were heat-inactivated at 70 C for 2 hr.
Culture of primary murine polymorphonuclear leukocytes (PMNs)
Mice (C57Bl6) were anesthetized by isoflurane and sacrificed by neck dislocation. Bone marrow (BM) cells were flushed from femurs and tibias (ice cold PBS), centrifuged (300 g, 4 C for 5 min) and resuspended in 1 mL PBS. 1 mL of BM cell suspension was laid on a three-layer Percoll (Sigma) gradient (72% (3 ml) / 64% (3 ml) / 52% (3 ml)) and centrifuged at 1000 g for 30 min with the brake switched off to avoid mixing of the three layers. PMNs were harvested from the 64% / 72% interface, washed in PBS and cultured overnight in VLE-RPMI 1640 medium (Biochrom) supplemented with 10% FBS and 100 U/ml penicllin and 100ug/ml streptomycin.
METHOD DETAILS
Inhibitors and blocking antibodies aIIbb3 inhibition: C7E3-Fab (Reopro, Lilly) (10 mg/ml), a blocking b3-specific Fab-fragment (Coller, 1985) . avb3 inhibition: LM609 (blocking antibody; Merck Millipore) (30mg/ml). Inhibition of actin polymerization: Cytochalasin D (Sigma) (2 mM) Myosin IIa inhibition: Blebbistatin(-) (Cayman Chemical) (5 mM or 50 mM); Blebbistatin(+) (Cayman Chemical) was used as negative control. Extracellular calcium depletion: 100 mM citrate. Intracellular calcium depletion: BAPTA-AM (10 mM) (Molecular Probes), Inhibition of Arp2/3: CK666 (50mM) (Sigma).
2P-IVM of vascular injury and bone marrow megakaryocytes
Mice were anaesthetized by intraperitoneal injection of a solution of midazolame (5 mg/kg body weight; Ratiopharm), medetomidine (0.5 mg/kg body weight; Pfizer), and fentanyl (0.05 mg/kg body weight; CuraMed Pharma GmbH). Mice were placed in a lateral position to allow careful immobilization of the ear-pinnae (ventral side up) to a custom-built imaging platform using 30G needles, as previously reported. A 3 mm x 3 mm piece of dermis was carefully removed to expose small subcutaneous veins. Two injury models were used to subsequently induce vascular injury. We either mechanically injured the vessel wall with a 30G needle or disrupted the vascular integrity by focusing a high power laser-beam of our two-photon microscope onto the vessel wall. Both injury models, triggered the exposure of subendothelial collagen as well as the accumulation of fibrin(ogen) at the site of injury ( Figure S1C ) and are established models to study hemostasis (Stalker et al., 2013) . To exclude passive platelet movement imitated by migrating leukocytes, we depleted leukocytes by i.p. injection of anti-Ly6G/C (150 mg/mouse 24 h and 4 h prior to injury; clone RB6-8C5, eBioscience) and anti-CD45 (100 mg/mouse 24 h prior to injury; clone 30-F11, eBioscience) (Daley et al., 2008) . Depletion efficiency was locally controlled by injection of fluorescently labeled (PE) anti-CD45 (eBioscience) and anti-Ly6G/C (clone RB6-8C5; eBioscience) following the experiment, and white blood cells were counted, using an automated cell counter (ABX Micros ES60, Horiba Medical) ( Figures S1G and S1H ). Images were acquired using a Trimscope II multi-photon imaging platform (LaVision Biotech) on an upright Olympus stand, enclosed in a custom-built incubator maintaining 37 C. Images were acquired using a Plan-Apochromat 20x/1.0 NA objective (Carl Zeiss Microscopy) with saline as immersion medium. Fluorescent signals were collected using 4 external/non-descanned photomultipliers (PMTs). For imaging of Confetti fluorescence the following filter combination was used: mCFP was collected with a 480/40 nm bandwidth and 520 nm longpass filter cYFP with a 535/30 nm bandwith and the same 520 nm longpass filter and cRFP with a 605/70 nm band-width and 560 nm longpass filter. Fluorescence excitation was provided by a Chameleon Ti:Sapphire laser (Coherent) tuned to 910 nm for simultaneous excitation of cYFP, cRFP and mCFP and generation of collagen second harmonic signal. 800 nm excitation wavelength was used for imaging of CFDA-SE, DDAO-SE, Alexa488 and Alexa546 and PE using the same laser. Z stacks were recorded with 2mm step-size and time series were captured with 1 frame every 5 s, unless otherwise specified. To visualize megakaryocytes in PF4-Cre/R26R-Confetti-mice we performed 2P-IVM of the mouse calvarian bone marrow. To get access to the frontoparietal skull, the scalp of an anesthetized mouse is incised in the midline. A plastic ring is inserted in the incision to spread the skin and to allow application of sterile physiologic saline solution to prevent drying of the tissue. During these procedures the animal's head is immobilized in a customized plexiglas stage equipped with a stereotactic holder. Imaging is performed using the multiphoton imaging platform as described above.
2P-IVM of liver microcirculation
Anesthetized mice (C57/Bl6) received tdTomato labeled E.coli (DH12) (3.2 3 10 8 CFU suspended in 200 mL saline) via the tail vein and platelets isolated from a PF4-Cre/Ai6(RCL-ZsGreen) donor mouse were transfused immediately prior to surgery. Plateletleukocyte binding was enhanced by i.v. injection of 25 mg LPS /mouse (Clark et al., 2007) . In some experiments leukocytes were fluorescently labeled using anti-Ly6G/C-FITC antibody (15mg/mouse; clone RB6-8C5, eBioscience). Where indicated in the figure legends, leukocyte depletion was performed as previously described by i.p. injection of anti-Ly6G/C (200 mg/mouse 24h prior to injury; clone RB6-8C5, eBioscience)). Surgical procedures were performed as previously described (Benechet et al., 2017) . Briefly, after opening the skin with a midline incision and detaching peritoneal adherences, midline and left subcostal incisions were made in the peritoneum through a high-temperature cautery. The falciform ligament was resected and mice were placed in a left lateral position with the left liver lobe gently exteriorized onto a glass coverslip attached to a custom-made imaging platform. The liver was covered with plastic wrap, the incision was packed with moist gauze, and the imaging platform was sealed to prevent dehydration. Images were acquired with a LaVision BioTec TriMScope II coupled to a Nikon Ti-U inverted microscope enclosed in a custom-built environmental chamber (Life Imaging Services) that was maintained at 37-38 C with heated air. Continuous body temperature monitoring through a rectal probe was performed to ensure that a narrow range of 37-38
C was maintained at all times. Fluorescence excitation was provided by two tunable fs-pulsed Ti:Sa lasers (680-1080 nm, Ultra II, Coherent). The setup includes four photomultiplier tubes (3 Hamamatsu H7422-40 GaAsP High Sensitivity PMTs and 1 Hamamatsu H7422-50 GaAsP High Sensitivity red-extended PMT) and a high working distance water-immersion 20x objective (NA = 1.0, Zeiss). Images were acquired every 10 s for up to 4 h. Images sequences were processed using FIJI (Schindelin et al., 2012) . X-Y Image drift was corrected using the StackReg plugin (Thé venaz et al., 1998) . Gaussian filtering was used to reduce image noise. Migrating cells were tracked manually using the ''Manual Tracking'' or the ''MTrackJ'' plugin in FIJI (Meijering et al., 2012) . Architecture of sinusoids was reconstructed from the smoothed auto-fluorescence signal of the liver (median filtered z-protection of the imaging sequence).
Systemic infection with E.coli Bone marrow (BM) chimeras were generated by injection of isolated bone marrow from PF4-Cre+/MYH9 fl/fl -or PF4-Cre-/ MYH9 fl/fl -mice into sublethally (900 rad) irradiated 8 weeks old recipient mice (sex: female; C57Bl6). Mice were used 24 weeks after reconstitution. Systemic infection with fluorescently labeled E.coli (DH12) (tdTomato) were performed as previously described (Massberg et al., 2010) . Briefly, E.coli at an amount of 3.2 3 10 8 CFU (suspended in 200 mL saline) was injected into the tail vein of mice (BM-Chimeras). 4 h after infection mice were sacrificed and livers were explanted, embedded in OCT and snap frozen in liquid nitrogen. Livers were cut with a cryotome into sections of 5mm thickness. Specimens were fixed with 4% formalin for 4 min, washed in PBS and stained for platelets (anti-CD42b, clone Xia.B, Emfret), E.coli (E. coli serotypes O + K Antibody, ThermoFisher) and/or fibrin(ogen) (4440-8004F, Bio-rad). Mosaic micrographs of liver sections were acquired using a Zeiss Axio Imager M2 epifluorescent microscope with a Plan Apochromat 40x/0.75 air objective and an AxioCam MRm camera (Carl Zeiss Microscopy). Images were analyzed using Imaris software (Bitplane).
Systemic infection with Staph. aureus (MRSA USA300) Mice were intravenously injected with 2*10 8 CFU of S. aureus USA300. Mice were sacrificed after 6h of infection. CFU-Assay Mice (PF4-Cre+/MYH9
fl/fl (age: 12-14 weeks, sex: 2 females and 3 males) or PF4-Cre-/MYH9 fl/fl (age: 12-14 weeks, sex: 2 females and 3 males) were sacrificed and organs were harvested and placed in phosphate buffered saline (DPBS, Dulbecco GIBCO) at 4 C until further processing. Organs were homogenized using a QIAGEN TissueLyser TM with an oscillation of 50/s for 10 min. Serial dilutions were made in BHI and plated on MRSA II (Oxoid, ThermoFischer Scientific) and LB plates. Plates were incubated for 20 h at 37 C. Figure S7D ) (depletion group: age: 9 weeks, sex: 3 females and 3 males; isotype control group: age: 9 weeks, sex: 3 females and 3 males) were generated by i.v. injection of anti-GPIba antibodies (2mg/g mouse; R300, Emfret). Mice were infected 12 h after treatment.
Plasma isolation
Mice (PF4-Cre+/MYH9 fl/fl (age: 12-14 weeks, sex: 2 females and 3 males) and PF4-Cre-/MYH9 fl/fl (age: 12-14 weeks, sex: 2 females and 3 males) were sacrificed and blood was drawn intracadially. Plasma was isolated from citrated whole blood by centrifugation at 1500 g for 15 min at 4 C and subsequently snap frozen in liquid nitrogen. Samples were stored at À80 C. Plasma ALT activity Serum levels of the liver enzyme ALT were determined with the alanine aminotransferase (ALT) activity fluorimetric assay kit from Biovision (Milpitas, CA, USA) according to the manufacturer's protocol. All necessary biochemical components were provided in the assay kit. Briefly, 5 mL blood serum was used to analyze the transformation of a-ketoglutarate with alanine to glutamate and pyruvate. The pyruvate is further converted, resulting in fluorescence (Ex/Em = 535/587 nm). The fluorescence was monitored on a Synergy Mx microplate reader (BioTek, Bad Friedrichshall, Germany) every 2 min for 2 h and ALT activity calculation was performed using measurements in the linear range of the standard curve.
Survival experiments Mice (PF4-Cre+/MYH9
fl/fl (age: 17-40 weeks; sex: 10 females and 1 male) or PF4-Cre-/MYH9 fl/fl (age: 17-40 weeks; sex: 9 females and 2 males) were intravenously injected with 2*10 8 CFU of S. aureus USA300. Infected mice were continuously monitored for a maximum of 24h (all mice died within the observation time).
Adoptive Transfer
Adoptive transfer of WT (C57/Bl6) and MYH9-deficient platelets into thrombocytopenic GPIb;hIL4R-Tg recipient mice (mice receiving WT plts: age: 10 weeks, sex: 2 males and 1 female; mice receiving MYH9À/À plts: age: 10 weeks, sex: 2 males and 1 female) was performed as previously described (Boulaftali et al., 2013) with small modifications: A, Platelet depletion Thrombocytopenia was induced in GPIb;hIL4R-Tg mice by i.v. injection of antibodies against hIL-4R (MAB230, R&D, 5 mg/g body weight; 12 h and 3h before transfusion).
B, Platelet transfusion
Washed platelets were isolated as described below. Platelets from several donor mice were pooled, and the platelet count was adjusted to 5 3 10 8 platelets/200 ml. Recipient mice were injected with 200 mL washed platelets. C, Flow cytometry For determination of endogenous and transfused platelet counts, diluted whole blood was stained with anti-hIL-4R-PE (FAB230P, R&D), and fraction of hILR4 positive platelets was assessed by flow cytometry (LSRFortessa; BD Biosciences).
Confocal imaging of platelets and megakaryocytes
Isolated washed platelets were incubated on fibrinogen coated coverslips (100 mg/ml) in the presence of 0.1 U/ml bovine Thrombin for 20 min at 37 C and subsequently imaged without prior fixation. Motility assays of confetti aggregates were performed using the migration assay as described below with adapted platelet concentrations (50x10 3 /ml). Megakaryocytes (MKs) were isolated as previously described (Mazharian et al., 2011) . Briefly, BM cells were flushed from femurs and cultured in serum-supplemented StemPro medium (2.6%) with 2mM l-glutamine, penicillin/streptomycin, and 20 ng/mL of murine stem cell factor at 37 C under 5% CO 2 for 2 days. Cells were then cultured for a further 4 days in the presence of 20 ng/mL of stem cell factor and 50 ng/mL of TPO. Mature MKs were enriched using a 1.5%/3% BSA gradient under gravity (1g) for 45 minutes at room temperature. MKs were allowed to spread on fibrinogen-coated coverslips (100 mg/ml) for 6 h at 37 C and imaged without prior fixation. Images were captured on an inverted Zeiss LSM 780 confocal microscope using a Plan-Apochromat 100x/1.46 oil-immersion objective (Carl Zeiss Microscopy).
Isolation and staining of human and murine platelets Human blood was drawn from the cubital into a syringe containing 1/7 volume of Acid-Citrate-Dextrose (39 mM citric acid, 75 mM sodium citrate, 135 mM dextrose; ACD). Blood from a patient with type I Glanzmann thrombasthenia was collected after approval from the ethical review board and written informed consent. Whole blood was diluted 1:1 with modified Tyrode's buffer (137 mM NaCl, 2.8 mM KCl, 12 mM NaHCO3, 5.5 mM glucose, 10mM HEPES, pH = 6.5) and centrifuged with 70 g for 30 min at RT with the break switched off. The supernatant contains the platelet rich plasma (PRP), either used for experiments or transferred into a second tube to prepare washed platelets. Platelets were washed by further diluting PRP (1:3) with PGI2 (0.1 mg/ml, Abcam) -containing, modified Tyrode's buffer (pH = 6.5) followed by centrifugation with 1250 g for 10 min at RT. The pellet was then carefully re-suspended in modified Tyrode's buffer (pH = 7,4) and platelets were counted with an automated cell counter (ABX Micros ES60, Horiba Medical). Mouse blood was drawn intracardially from anesthetized (isoflurane (DeltaSelect), fentanyl i.p. (0.05 mg/kg body weight; CuraMed Pharma)) mice and processed as described for human platelets. For some experiments platelets were stained with either 4.5 mM CFDA-SE (Carboxyfluorescein diacetate succinimidyl ester, Molecular Probes) or 4.5 mM DDAO-SE (CellTrace Far Red, Molecular Probes) for 30 min at room temperature, followed by additional washing with modified Tyrode's buffer (pH = 6.5).
Plasma and serum preparation Platelet poor plasma (PPP) was isolated from human or mouse anti-coagulated whole blood (ACD 1:7) and diluted in modified Tyrode's buffer (pH = 7.4) (1:1); followed by centrifugation with 1750 g for 10 min at RT. PPP from the supernatant was either used for experiments or further processed to generate serum. PPP was incubated with bovine thrombin (1 U/ml, Sigma) for 30 min at RT to initiate coagulation. Fibrin was removed from the solution by centrifugation (2000 g, 15 min, RT) and thrombin activity was blocked by adding 2U/ml Lepirudin (Refludan, Schering) and 40 mM PPACK (D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone, Enzo Life Science) . To determine the protein concentration of serum, Bradford assays were performed (Quick Start Bradford Protein Assay, Bio-Rad) using bovine serum albumin (BSA) as protein standard. In some experiments, serum was further processed. To heat-denature serum proteins, samples were incubated at 37 C, 50 C, 70 C and 90 C (Thermomixer, Eppendorf) for 30 min and cooled down to RT prior to the experiment. To fractionate serum by size and to remove low molecular components, dialysis was performed against PBS using dialysis cassettes of 2 kDa molecular weight cut-off (Slide-A-Lyzer Dialysis Cassettes, Thermo Scientific).
Preparation of platelet supernatants
Supernatants of collagen-activated platelets were generated from PRP pre-incubated with 10 mg/ml fibrillar collagen (Chrono-Log) for 20 min at 37 C. Some preparations were performed in the presence of 2 U/ml apyrase (New England Biolabs) and 10 mM indomethacin (Sigma) or vehicle (Succinate buffer or Ethanol). Activated platelets were removed by centrifugation at 9000 g for 10 min and PPP containing the platelet releasate was used for experiments.
Functionalization of coverslips and migration assay Plasma-coated coverslips A plastic ring was glued to a coverslips (Desag 263 low alkaline glass, Bioptechs) to build a custom made migration chamber. The chamber was filled with modified Tyrode's buffer (pH = 7.4) supplemented with isolated plasma (1:1) and platelet activators (4 mM ADP (Sigma) / 2 mM U46619 (Tocris Bioscience)). Within 5 min at RT the coverslips were coated with a homogeneous protein layer (Turbill et al., 1996) as verified by AFM and immunostainings (see Figures S3H and S3I) . Finally, PRP was added to reach a final concentration of 10x10 6 platelets/ml. In some experiments, coating with fibrillar collagen (fCol) and plasma was performed by incubating coverslips with 200mg/ml fCol (Chrono-log) in plasma/thyrodes 7.4 (1:1) for 2 h at RT before adding PRP. Serum/Fibrinogen-coated coverslips A plastic ring was glued to coverslips (Desag 263 low alkaline glass, Bioptechs) to build a custom-made migration chamber. The chamber was filled with modified Tyrode's buffer (pH = 7.4) supplemented with isolated serum (concentrations as indicated), fibrinogen (concentrations as indicated) and platelet activators (4 mM ADP (Sigma) / 2 mM U46619 (Tocris Bioscience)). Washed platelets were added to reach a final concentration of 10x10 6 platelets/ml.
HSA/Fibrinogen-coated coverslips Coverslips (No. 1.5, D263T, Nexterion) were acid washed (20% HNO 3 ) for 1 hour at RT and thoroughly rinsed in ddH2O for another hour. Freshly cleaned coverslips were air-dried and silaned with hexamethyldisilazane (HMDS, Sigma) by spin-coating at 80 rps for 30 s. A plastic ring was glued to the pretreated coverslips to build a custom made migration chamber. Migration buffer containing modified Tyrode's buffer (pH = 7.4) was supplemented with adhesive proteins (fibrinogen (Sigma) or fibrinogen-Alexa488(À10 nm-gold) (Invitrogen)) and anti-adhesive proteins (rHSA (Sigma) or Casein (Sigma) or Ovalbumin (Sigma)), platelet activators (ADP (Sigma) / U46619 (Tocris Bioscience)) and divalent cations (calcium) at the concentrations indicated. If not otherwise stated the following concentrations were used: rHSA (1500 mg/ml) or casein (30mg/ml); fibrinogen (150 mg/ml), calcium (200 mM), ADP (4 mM), U46619 (2 mM). Washed platelets were added to the migration buffer to reach a final concentration of 10x10 6 platelets/ml.
HSA/Fibrin(ogen)-Alexa488-coated coverslips Coverslips were silaned as described above. To improve imaging quality, plastic channels (sticky slides, Ibidi) were used instead of plastic rings to build the migration chamber. Fibrinogen-Alexa488 coating: Channels were incubated with modified Tyrodes (pH 7.4) supplemented with 40 mg/ml Fibrinogen-Alexa488 (Invitrogen) and 2 mg/ml rHSA (Sigma) for 15 min at RT. Fibrin-Alexa488 coating: Channels were incubated with modified Tyrodes (pH 7.4) supplemented with 300 mg/ml Fibrinogen (Sigma) (1:10 spiked with Fibrinogen Alexa488 (Invitrogen)), 12 mg/ml rHSA (Sigma), 2U/ml bovine Thrombin (Sigma), 1 mM Calcium for 15 min at RT. After coating, slides were washed with PBS and washed platelets (10x10 6 /ml) in modified Tyrodes buffer (pH 7.4) supplemented with plasma, antiadhesive proteins, platelet activators, and divalent cations (see above) were added.
Immobilization of beads
Fibrinogen was biotinylated using the EZ-LinkSulfo-NHS-SS-Biotin kit (Thermo Fisher). HSA/Fibrinogen-coated slides were prepared as described above. Neutravidin-conjungated-200 nm (or 1 mm)-beads (FluoSpheres, Molecular Probes) were immobilized on biotinylated-Fibrinogen monolayers via the biotin-neutravidin bond. Immobilization of bacteria Bacteria (E.coli or L. monocytogenes or MRSA USA300 or inactivated Staph. aureus) were incubated on fibrin-coated slides (see above) for 30-60min h at 37 C. Slides were washed with Thyrodes buffer (pH 7.4) to remove non-adherent bacteria. Washed platelets (10x10 6 /ml) in modified Tyrodes buffer (pH 7.4) supplemented with plasma, anti-adhesive proteins, platelet activators, and divalent cations (see above) were added. In all experimental settings, platelet spreading and migration were subsequently observed using time-lapse video microscopy.
Characterization of plasma coated surfaces Atomic force microscope (AFM) measurements were performed on a NanoWizard-II (JPK Instruments) AFM in ambient conditions. The AFM was operated in tapping mode, to minimize abrasion of the molecule layer by the AFM tip. Silicon cantilevers (BS Tap 300, Budget Sensors) with typical spring constants of 40 N/m and nominal resonance frequencies of 300 kHz were used. The nominal tip radius was smaller than 10 nm. The images were analyzed using SPIP (SPIP 4.5.2, Image Metrology).
Immunostainigs of fixed plasma coated coverslips were performed using the following primary antibodies (anti-fibrinogen (ab34269, Abcam), anti-vWF (ab6994, Abcam), anti-fibronectin (ab2413, Abcam)). Slides were incubated with antibodies for 1 h at RT, washed with PBS and stained with Alexa 488 labeled secondary antibodies (Molecular Probes) for another hour.
Time-lapse video microscopy Differential interference contrast (DIC), Phase Contrast and Epifluorescence movies (1frame/12 s) were recorded on an automated inverted IX83 Olympus microscope with an UPlan 40x/1.0 or UPLSAPO-PH 100x/1.4 oil-immersion objective (Olympus) and a cooled CCD camera (XM10, Olympus). The microscope was equipped with a stage incubator (37 C, humidified, Tokai Hit).
Flow chamber assay
To observe platelet migration under flow conditions plasma-coated (see above) circular glass coverslips (40mm, Bioptechs) were placed into a parallel plate flow chamber (FCS2, Bioptechs) and incubated with migration buffer and PRP (10x10 6 platelets/ml).
Once platelets were fully spread the flow-chamber was perfused with pre-warmed migration buffer (37 C; shear rate: 1300/s) using a recirculating air pressure pump (Ibidi) and migration was observed by time-lapse microscopy.
Bacterial trapping experiment under flow E.coli were seeded on fibrin (Alexa488-labeled)-coated coverslips in the presence or absence of platelets for 1 hour at 37 C (see above). Microfluidic channels were then assembled (ibidi sticky slides VI 0.4 (ibidi)), connected to a syringe pump and placed on an inverted microscope (IX83, Olympus) with a heated stage. Channels were perfused with modified Tyrode's buffer (see above, 37 C) at 0.5 dyne/cm 2 to remove non-adhering bacteria. After 1 min Tyrode's buffer was perfused at 5 dyne/cm 2 for 5 min and subsequently at 50 dyne/cm 2 for 30 s. Images were taken after each perfusion step. Number and size of trapped bacteria was quantified manually using FIJI software (Schindelin et al., 2012) . Bacteria were extracted from phase-contrast images and pseudo-colored in magenta.
Platelet phagocytosis assay
Human Fibrinogen (Sigma) was biotinylated with cleavable Sulfo-NHS-SS-Biotin using the EZ-LinkSulfo-NHS-SS-Biotin kit purchased from Thermo Fisher. Coverslips were then coated with Fibrinogen-Biotin and platelet migration experiments were performed as described above. Fibrinogen-Biotin removed from the surface and accumulated at the migrating platelet was traced by fluorescent labeling using Streptavidin-Alexa488 (SA488) (Invitrogen). Taking advantage of the cleavable SS-Biotin bond we designed 3 sets of experiments to determine the site of Fibrinogen accumulation (intracellular versus extracellular) (also see Figure S5D ). I. Platelets were incubated with SA488 without further treatment; II. SS-Biotin was cleaved using TCEP (Tris-(2-carboxyethyl)-phosphin) (Sigma) prior to SA488 incubation; III. Platelets were permeabilized with Saponin and SS-Biotin was cleaved using TCEP prior to SA488 incubation. Mean fluorescence intensities (Alexa488) of platelet pseudonuclei were recorded for each condition. Fibrinogen localization (extracellular versus intracellular) was determined by comparing the relative loss of fluorescence in all conditions (also see Figure S5D ).
Platelet tracking protocol
Spreading platelets (migrating and non-migrating) were counted manually and tracked using the ''Manual Tracking'' or the ''MTrackJ'' plugin in FIJI (Schindelin et al., 2012 , Meijering et al., 2012 . The fraction of migrating platelets was calculated by dividing the number of migrating platelets by the total number of spreading (migrating and non-migrating) platelets. The pseudonucleus of a migrating platelet served as a morphological landmark for tracking. Platelets moving a distance R 1 platelet diameter were classified as migrating. In some experiments, the straightness of migration was calculated by dividing the Euclidean distance of migration by the accumulated distance of migration. The directionality toward a vessel injury was quantified by the forward migration index (FMI), defined by the ratio of the fractional displacement along the line connecting starting point of migration and injury and the total accumulated distance of migration; maximal directionality = 1; minimal directionality = À1. The duration of platelet migration is plotted in respect to the initial starting-point within the observation time and duration effective / duration max defines the ratio of the effective duration of migration or spreading and the maximum duration possible in respect to the initial starting-point. For representation of in vivo migration tracks the starting points were normalized to zero and plotted in respect to the direction of blood flow or the localization of the vessel injury. Heatmaps illustrating retraction speed and fibrinogen removal were generated using QFSM software (Mendoza et al., 2012) .
Shape analysis
We performed an unbiased, systematic analysis of platelet shapes to analyze the morphological variations of migrating and non-migrating platelets without pre-selecting particular shape measurements (e.g., area or cell-diameter). Platelet shapes were represented as polygonal outlines and principal component analysis (PCA) was performed to extract principal modes of shape variation along which to measure each platelet. Platelet shapes from DIC movies were manually masked and converted into binary images using FIJI (Schindelin et al., 2012) . Polygonal outlines were extracted from masks and sampled at evenly spaced 200 points. To ensure that all polygons were orientated equally, an algorithm based on Procrustes analysis was used to rotate and translate the polygons until corresponding points were optimally aligned. Next, we used the pseudonucleus as a characteristic landmark defining the rear of a migrating platelet. The pseudonuclei were manually marked in FIJI and extracted to another set of binary images. This additional landmark was also used in the Procrustes procedure and improved the alignment. Finally, the alignment was manually verified. Aligned contours were further analyzed by principle component analysis. The principle components, scaled by the standard deviation of the analyzed population for each mode of shape were depicted. To explore whether the classified shape modes allow the discrimination of functionally distinct platelet subpopulations (e.g., migrating versus non-migrating), platelet polygons were arrayed in a scatterplot. Finally, the following cellular characteristics were measured based on shape modes detected by PCA: (1) Area in mm 2 (mode 1) and (2) Aspect Ratio = long axis/short axis (mode 2). In some experiments polygon curvature was measured as an approximation of membrane roughness. The average of the absolute values of the point wise curvature of the contour is computed over a specified range, and multiplied by the contour length over the same range. Absolute values must be used because otherwise positive and negative curvatures would cancel out; the sum is multiplied by the arc length to make the measurement scale-invariant. All algorithms are implemented in the ''Celltool'' software package (Pincus and Theriot, 2007) . To analyze the spatio-temporal coordination of leading-edge protrusion and trailing edge retraction kymographs were extracted along the central axis of migrating platelets.
Immunofluorescence of migrating platelets Polarized, migrating or spread, non-migrating platelets were fixed at 37 C in 1% paraformaldehyde for 10 min. Platelets were washed three times with PBS and incubated with 2% Glycin (Roth) for 5 min, followed by incubation with 0.2% Triton X-100 (Fluka) and 3% bovine serum albumin (Roth), to permeabilize the cells and to block unspecific binding, respectively. For aIIbb3 staining, platelets were incubated for 1 h at RT with primary antibodies (1:50, clone HIP8, Abcam) followed by 1 h at RT with secondary antibodies (goat anti-mouse IgG Alexa488, 1:200, A11001, Molecular Probes). Activated aIIbb3 was stained in live cells during migration for 20min (PAC1-FITC, 1 mg/ml, BD) followed by incubation for 1 h at RT with secondary antibodies (rabbit anti-FITC Alexa488, 1:200, A11090, Molecular Probes). Filamentous actin was stained by Rhodamin-Phalloidin (1:40, Molecular Probes).
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical parameters, including the exact value of replicates (''n'') for individual experiments can be found within the figure legends. t tests and analysis of variance (ANOVA) were performed after data were confirmed to fulfill the criteria of normal distribution (Kolmogorov-Smirnov-test), otherwise Kruskal-Wallis-or wilcox-rank-sum-tests were applied. If overall ANOVA or KruskalWallis-tests were significant, we performed a post hoc test (Tukey-HSD for ANOVA and wilcox-rank-sum post hoc test for Kruskal Wallis, respectively). In matched-sample experiments, the paired t test was used. Survival was analyzed using the log rank test. A p value of < 0.05 was considered statistically significant. Analyses were performed with R (http://www.r-project.org/; R Core Team, 2014) 
